Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL803601 | 0.87 | ALDH1A1 (0.44) | EDNRAKMT2AMEN1TAS1R3TAS1R1 | |
| SCHEMBL15897079 | 0.85 | EDNRA (0.46) | EDNRAKMT2AMEN1OPRM1OPRD1 | |
| Hydrochloric Acid SCHEMBL786185 | 0.84 | EDNRA (0.46) | EDNRAKMT2AMEN1OPRM1OPRD1 | |
| SCHEMBL803787 | 0.82 | EDNRA (0.56) | EDNRAKMT2AMEN1TAS1R3TAS1R1 | |
| SCHEMBL803897 | 0.79 | EDNRA (0.46) | EDNRAKMT2AMEN1TAS1R3TAS1R1 | |
| SCHEMBL803824 | 0.76 | EDNRA (0.54) | EDNRAKMT2AOPRM1OPRD1TAS1R3 | |
| SCHEMBL15896801 | 0.74 | ALDH1A1 (0.38) | EDNRAKMT2AMEN1TAS1R3TAS1R1 | |
| Bromide SCHEMBL786345 | 0.73 | ALDH1A1 (0.37) | EDNRAKMT2AMEN1TAS1R3TAS1R1 | |
| SCHEMBL15896809 | 0.72 | KMT2A (0.39) | EDNRAKMT2AMEN1TAS1R3TAS1R1 | |
| Bromide SCHEMBL786195 | 0.72 | KMT2A (0.40) | EDNRAKMT2AMEN1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | disclosed |
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | disclosed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | disclosed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071661-A1 | Ionic Liquid Solvents | EBP, PAICS, HACD3 | EDNRA 3492/4885KMT2A 3968/4885MEN1 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.